Cencora, Inc. $COR Shares Acquired by Black Creek Investment Management Inc.

Black Creek Investment Management Inc. increased its holdings in Cencora, Inc. (NYSE:CORFree Report) by 8.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 46,725 shares of the company’s stock after acquiring an additional 3,734 shares during the quarter. Cencora makes up 0.8% of Black Creek Investment Management Inc.’s portfolio, making the stock its 17th biggest position. Black Creek Investment Management Inc.’s holdings in Cencora were worth $15,781,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. AustralianSuper Pty Ltd bought a new stake in Cencora in the third quarter valued at about $26,191,000. Chilton Investment Co. Inc. bought a new stake in Cencora in the third quarter valued at about $459,000. Lansforsakringar Fondforvaltning AB publ increased its holdings in Cencora by 5.4% in the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock valued at $18,831,000 after buying an additional 3,073 shares during the last quarter. Nordea Investment Management AB increased its holdings in Cencora by 3.8% in the fourth quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after buying an additional 45,712 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in Cencora by 57.0% in the fourth quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock valued at $22,724,000 after buying an additional 24,431 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

COR has been the subject of several recent research reports. Weiss Ratings lowered Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Citigroup lowered their target price on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Wells Fargo & Company lowered their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Finally, Robert W. Baird lowered their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Cencora has an average rating of “Moderate Buy” and an average target price of $374.00.

View Our Latest Stock Report on Cencora

Cencora Stock Performance

COR opened at $281.56 on Friday. The company has a market capitalization of $54.78 billion, a price-to-earnings ratio of 21.59, a price-to-earnings-growth ratio of 1.52 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The business has a 50 day moving average price of $289.22 and a two-hundred day moving average price of $327.63.

Cencora (NYSE:CORGet Free Report) last released its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the company earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Research analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio is 18.40%.

Cencora announced that its board has authorized a share repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Cencora Profile

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

Read More

Institutional Ownership by Quarter for Cencora (NYSE:COR)

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.